STAAR upgraded

|About: STAAR Surgical Company (STAA)|By:, SA News Editor

Canaccord Genuity upgrades STAAR Surgical (STAA) to Buy with a price target of $20.

Consensus estimates for 2014 and 2015 are EPS of $0.17 on revenues of $80M and EPS of $0.44 on revenues of $93M, respectively.

The firm announces a positive ad comm vote for its Vision Implantable Lens (TICL).

163 mutual funds have positions, up from 126 a year earlier.